Literature DB >> 7385089

Cryptogenic fibrosing alveolitis: clinical features and their influence on survival.

M Turner-Warwick, B Burrows, A Johnson.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 7385089      PMCID： PMC471249          DOI： 10.1136/thx.35.3.171

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  8 in total

1.  DIFFUSE INTERSTITIAL PULMONARY FIBROSIS.A CLINICAL, RADIOLOGICAL, AND PATHOLOGICAL STUDY BASED ON 45 PATIENTS.

Authors:  J L LIVINGSTONE; J G LEWIS; L REID; K E JEFFERSON
Journal:  Q J Med       Date:  1964-01

2.  The prognosis of cryptogenic fibrosing alveolitis.

Authors:  B H Stack; Y F Choo-Kang; B E Heard
Journal:  Thorax       Date:  1972-09       Impact factor: 9.139

3.  Antibodies in some chronic fibrosing lung diseases. II. Immunofluorescent studies.

Authors:  M Turner-Warwick; P Haslam; J Weeks
Journal:  Clin Allergy       Date:  1971-06

4.  Natural history and treated course of usual and desquamative interstitial pneumonia.

Authors:  C B Carrington; E A Gaensler; R E Coutu; M X FitzGerald; R G Gupta
Journal:  N Engl J Med       Date:  1978-04-13       Impact factor: 91.245

5.  Antibodies in some chronic fibrosing lung diseases. I. Non organ-specific autoantibodies.

Authors:  M Turner-Warwick; P Haslam
Journal:  Clin Allergy       Date:  1971-03

Review 6.  Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects.

Authors:  R G Crystal; J D Fulmer; W C Roberts; M L Moss; B R Line; H Y Reynolds
Journal:  Ann Intern Med       Date:  1976-12       Impact factor: 25.391

7.  Circulating immune complexes in the idiopathic interstitial pneumonias.

Authors:  R B Dreisin; M I Schwarz; A N Theofilopoulos; R E Stanford
Journal:  N Engl J Med       Date:  1978-02-16       Impact factor: 91.245

8.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640
  8 in total
  75 in total

Review 1.  Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis.

Authors:  A Wells
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

Review 2.  In search of a cause of cryptogenic fibrosing alveolitis (CFA): one initiating factor or many?

Authors:  M Turner-Warwick
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

Review 3.  Interferon gamma-1b therapy for cryptogenic fibrosing alveolitis.

Authors:  J Britton
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

4.  Serum KL-6 levels in patients with pulmonary complications after allogeneic bone marrow transplantation.

Authors:  T Ashida; M Higashishiba; Y Sumimoto; T Sano; H Miyazato; T Shimada; J Miyatake; K Kawanishi; Y Tatsumi; A Kanamaru
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

Review 5.  Review of cryptogenic fibrosing alveolitis, including current treatment guidelines.

Authors:  S C Bourke; H Clague
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 6.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

7.  A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis.

Authors:  M Clark; B Cooper; S Singh; M Cooper; A Carr; R Hubbard
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

8.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-2002. A 56-year-old man with rapidly worsening dyspnea.

Authors:  Michelle Ng Gong; Eugene J Mark
Journal:  N Engl J Med       Date:  2002-12-26       Impact factor: 91.245

9.  High resolution computed tomography as a predictor of lung histology in systemic sclerosis.

Authors:  A U Wells; D M Hansell; B Corrin; N K Harrison; P Goldstraw; C M Black; R M du Bois
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139

10.  Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts.

Authors:  D W Mapel; W C Hunt; R Utton; K B Baumgartner; J M Samet; D B Coultas
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.